ChIP-seq to identify binding sites of the fusion oncogene CBFA2T3::GLIS2 in WSU-AML cell line

ABSTRACT: CBFA2T3::GLIS2 was fused with GFP through CRISPR-Cas9 in WSU-AML cells. Cells were then used for ChIP-seq using a GFP antibody in order to determined the CBFA2T3::GLIS2 fusion binding sites.

INSTRUMENT(S): Illumina NovaSeq 6000

ORGANISM(S): Homo sapiens

SUBMITTER: Thomas MERCHER 

PROVIDER: E-MTAB-14187 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress